IDNA | Carelon Clinical Guidelines and Pathways

Carelon Medical Benefits Management clinical appropriateness guidelines and cancer treatment pathways

Home 9 Tag: IDNA ( Page 8 )

ARCHIVED Hereditary Cancer Susceptibility 2020-09-01 to 2021-01-03

by dlamm | Jan 4, 2021 | Archived

ARCHIVED Whole Exome and Whole Genome Sequencing 2020-03-03 to 2020-08-31

by dlamm | Sep 1, 2020 | Archived

ARCHIVED Hereditary Cardiac Disease 2020-03-03 to 2020-08-31

by dlamm | Sep 1, 2020 | Archived

ARCHIVED Solid and Hematologic Tumors 2020-03-03 to 2020-08-31

by dlamm | Sep 1, 2020 | Archived

ARCHIVED Hereditary Cancer Susceptibility 2020-03-03 to 2020-08-31

by dlamm | Sep 1, 2020 | Archived

« Older Entries

Next Entries »